These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 31897874)
21. Effect of systemic atherosclerosis on overactive bladder symptoms in men with benign prostatic hyperplasia. Lee D; Koo KC; Yoo JW; Lee KS Low Urin Tract Symptoms; 2022 Jan; 14(1):35-40. PubMed ID: 34323012 [TBL] [Abstract][Full Text] [Related]
22. Correlation between intravesical prostatic protrusion and international prostate symptom score among Nigerian men with benign prostatic hyperplasia. Eze BU; Mbaeri TU; Oranusi KC; Abiahu JA; Nwofor AM; Orakwe JC; Mbonu OO Niger J Clin Pract; 2019 Apr; 22(4):454-459. PubMed ID: 30975947 [TBL] [Abstract][Full Text] [Related]
23. The Effect of Intravesical Prostatic Protrusion in Patients with Benign Prostatic Hyperplasia: Controlled, Clinical Study. Kadihasanoglu M; Aydin M; Taskiran M; Kendirci M Urol Int; 2019; 103(2):180-186. PubMed ID: 31039569 [TBL] [Abstract][Full Text] [Related]
24. Comparison between prostate volume and intravesical prostatic protrusion in detecting bladder outlet obstruction due to benign prostatic hyperplasia. Hossain AK; Alam AK; Habib AK; Rashid MM; Rahman H; Islam AK; Jahan MU Bangladesh Med Res Counc Bull; 2012 Apr; 38(1):14-7. PubMed ID: 22545345 [TBL] [Abstract][Full Text] [Related]
25. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms. Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995 [TBL] [Abstract][Full Text] [Related]
26. Non-invasive evaluation of bladder outlet obstruction in benign prostatic hyperplasia: a clinical correlation study. Reddy SVK; Shaik AB Arab J Urol; 2019; 17(4):259-264. PubMed ID: 31723442 [No Abstract] [Full Text] [Related]
27. [Ultrasound indicators of the prostate, urinary bladder and uroflowmetry parameters in the diagnosis of infravesical obstruction in men with benign prostatic hyperplasia]. Krivoborodov GG; Efremov NS; Bolotov AD Urologiia; 2017 Oct; (5):9-14. PubMed ID: 29135135 [TBL] [Abstract][Full Text] [Related]
28. [Add-on effect of dutasteride in patients with benign prostatic hyperplasia treated with alpha blocker : its effect on overactive bladder]. Wada N; Hashidume K; Tamaki G; Kita M; Iwata T; Matsumoto S; Kakizaki H Hinyokika Kiyo; 2012 Sep; 58(9):475-80. PubMed ID: 23070385 [TBL] [Abstract][Full Text] [Related]
29. The Overactive Bladder Symptom Score, International Prostate Symptom Score-Storage Subscore, and Urgency Severity Score in Patients With Overactive Bladder and Hypersensitive Bladder: Which Scoring System is Best? Chuang FC; Hsiao SM; Kuo HC Int Neurourol J; 2018 Jun; 22(2):99-106. PubMed ID: 29991231 [TBL] [Abstract][Full Text] [Related]
30. Combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Suzuki T; Otsuka A; Ozono S Int J Urol; 2016 Nov; 23(11):929-933. PubMed ID: 27545297 [TBL] [Abstract][Full Text] [Related]
31. International Prostate Symptom Score for assessing lower urinary tract dysfunction in women. Hsiao SM; Lin HH; Kuo HC Int Urogynecol J; 2013 Feb; 24(2):263-7. PubMed ID: 22588143 [TBL] [Abstract][Full Text] [Related]
32. Is there any Relationship between Total Prostate Volume, Intravesical Prostatic Protrusion and Lower Urinary Tract Symptoms in Adult Nigerian Men with Benign Prostatic Enlargement? Raphael JE; Abhulimen V West Afr J Med; 2021 Jun; 38(6):578-582. PubMed ID: 34180211 [TBL] [Abstract][Full Text] [Related]
33. Correlation between overactive bladder symptoms and quality of life in Japanese male patients: focus on nocturia. Takao T; Tsujimura A; Kiuchi H; Takezawa K; Okuda H; Yamamoto K; Fukuhara S; Miyagawa Y; Nonomura N Urology; 2013 Jul; 82(1):189-93. PubMed ID: 23642937 [TBL] [Abstract][Full Text] [Related]
34. Epidemic investigation of benign prostatic obstruction with coexisting overactive bladder in Shanghai Pudong New Area and its impact on the health-related quality of life. Yi QT; Gong M; Chen CH; Hu W; Zhu RJ BMC Urol; 2019 Sep; 19(1):82. PubMed ID: 31481034 [TBL] [Abstract][Full Text] [Related]
35. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154 [TBL] [Abstract][Full Text] [Related]
36. What Are Factors Contributing to Improvement of Overactive Bladder Symptoms after Alpha-1 Blocker Treatment in Patients with Both Storage and Voiding Symptoms? Matsukawa Y; Majima T; Takai S; Funahashi Y; Kato M; Gotoh M Urol Int; 2019; 103(4):439-443. PubMed ID: 31554005 [TBL] [Abstract][Full Text] [Related]
37. Terminal dribbling in male patients with lower urinary tract symptoms: relationship with International Prostate Symptom Score and with intravesical prostatic protrusion. Kim JH; Shim JS; Choi H; Moon du G; Lee JG; Kim JJ; Bae JH; Park JY BMC Urol; 2015 Aug; 15():89. PubMed ID: 26319937 [TBL] [Abstract][Full Text] [Related]
38. What are the predicting factors for the therapeutic effects of dutasteride in male patients with lower urinary tract symptoms? Investigation using a urodynamic study. Matsukawa Y; Kato M; Funahashi Y; Majima T; Yamamoto T; Gotoh M Neurourol Urodyn; 2017 Sep; 36(7):1809-1815. PubMed ID: 28102554 [TBL] [Abstract][Full Text] [Related]
39. Assessment of noninvasive predictors of bladder outlet obstruction and acute urinary retention secondary to benign prostatic enlargement. Abdel-Aal A; El-Karamany T; Al-Adl AM; Abdel-Wahab O; Farouk H Arab J Urol; 2011 Sep; 9(3):209-14. PubMed ID: 26579300 [TBL] [Abstract][Full Text] [Related]
40. Is type-2 diabetes mellitus associated with overactive bladder symptoms in men with lower urinary tract symptoms? Bang WJ; Lee JY; Koo KC; Hah YS; Lee DH; Cho KS Urology; 2014 Sep; 84(3):670-4. PubMed ID: 25168549 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]